Phase III Clinical Trial Activities
Phase III Clinical Trial Activities. Means Phase III Clinical Trial and any additional preclinical or clinical studies in Japan required by the PMDA or any other regulatory authorities in Japan in order to obtain marketing approval for the Product in that indication in Japan.
All Definitions
Found in
Upstream Bio, Inc. contract
